Ketanserin tartrate

CAS No. 83846-83-7

Ketanserin tartrate ( R41468 tartrate )

Catalog No. M16108 CAS No. 83846-83-7

A high-affinity, non-selective antagonist of 5-HT2 receptor with Ki of 2-3 nM for 5-HT2A and 28 nM for 5-HT2C.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ketanserin tartrate
  • Note
    Research use only, not for human use.
  • Brief Description
    A high-affinity, non-selective antagonist of 5-HT2 receptor with Ki of 2-3 nM for 5-HT2A and 28 nM for 5-HT2C.
  • Description
    A high-affinity, non-selective antagonist of 5-HT2 receptor with Ki of 2-3 nM for 5-HT2A and 28 nM for 5-HT2C; also has a high affinity antagonist for the H1 receptor (Ki= 2 nM) and α1-adrenergic receptor (Ki=40 nM); an antihypertensive agent.Hypertension Approved
  • Synonyms
    R41468 tartrate
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    83846-83-7
  • Formula Weight
    545.51
  • Molecular Formula
    C26H28FN3O9
  • Purity
    >98% (HPLC)
  • Solubility
    H2O: 30 mg/mL (Need ultrasonic and warming)
  • SMILES
    O=C(N1CCN2CCC(C(C3=CC=C(F)C=C3)=O)CC2)NC4=C(C=CC=C4)C1=O.O[C@H]([C@H](C(O)=O)O)C(O)=O
  • Chemical Name
    2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Creed-Carson M, et al. Behav Brain Res. 2011 Jun 1;219(2):273-9.
2. Catafau AM, et al. J Cereb Blood Flow Metab. 2010 May;30(5):985-93.
molnova catalog
related products
  • JNJ-5234801

    JNJ-5234801 is an atypical anxiolytic targeting 5-HT2 receptor, has demonstrated oral activity in animal models of anxiety.

  • Cerlapirdine

    Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.

  • 17α-Estradiol

    Endogenous estrogen receptor ligand (Kivalues are 0.2 and 1.2 nM for ERαand ERβreceptors respectively).